Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Redwire Corporation (RDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Redwire Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while Redwire Corporation trades at $8.38 (market cap $2.29B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 13.6× Redwire Corporation's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Redwire Corporation pays none. Which is the better fit depends on your goals.
| GEHC | RDW | |
|---|---|---|
Market Cap | $31.07B | $2.29B |
Volume | 3,443,020 | 9,800,070 |
Sector | Health | Industrials |
52-Week High | $88.16 | $25.90 |
52-Week Low | $59.48 | $5.06 |
Enterprise Value | $39.53B | $1.82B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 18 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Redwire Corporation (RDW) trades at $9.16, down 0.65% on the day, showing bearish technical signals despite recent contract wins. The company reported strong revenue growth with Q2 2026 showing 89.6% year-over-year increase, but continues to post significant losses with a net income margin of -57.26%. Recent developments include a $981 million Space Force contract award and partnerships with Honda and Sophia Space for orbital infrastructure projects.
While analyst consensus remains bullish with an 80% buy rating and $14.88 price target, the stock faces substantial execution risks amid persistent losses and negative cash flow from operations. The company's growth trajectory depends heavily on successful contract execution and SpaceX's Starship development, making this a high-risk, high-potential investment in the emerging space economy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Redwire Corporation
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →
